IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · IEX Real-Time Price · USD
0.741
+0.001 (0.16%)
Jul 2, 2024, 3:36 PM EDT - Market closed
Company Description
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors.
The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors.
The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
IceCure Medical Ltd
Country | Israel |
Founded | 2006 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 71 |
CEO | Eyal Shamir |
Contact Details
Address: 7 Ha'eshel St., Pob 3163 Caesarea, L3 38900 Israel | |
Phone | 972-4-6230333 |
Website | icecure-medical.com |
Stock Details
Ticker Symbol | ICCM |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001584371 |
CUSIP Number | M53071136 |
ISIN Number | IL0011224156 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Eyal Shamir | Chief Executive Officer and Director |
Ronen Tsimerman CPA | Chief Financial Officer and Chief Operating Officer |
Tlalit Bussi Tel-Tzure | Vice President of Business Development and Global Marketing |
Merav Nir Dotan | Vice President of Human Resources |
Galit Malik | Vice President of Operations and Service |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jul 1, 2024 | 6-K | Report of foreign issuer |
Jun 4, 2024 | 6-K | Report of foreign issuer |
May 28, 2024 | 6-K | Report of foreign issuer |
May 21, 2024 | 6-K | Report of foreign issuer |
May 7, 2024 | 6-K | Report of foreign issuer |
Apr 15, 2024 | 6-K | Report of foreign issuer |
Apr 15, 2024 | 6-K | Report of foreign issuer |
Apr 3, 2024 | 6-K | Report of foreign issuer |
Apr 3, 2024 | 20-F | Annual and transition report of foreign private issuers |
Apr 2, 2024 | 6-K | Report of foreign issuer |